Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
US FDA declines to approve Corcept's drug for rare hormonal disorder - 2Which restaurants and fast food chains will be open on Christmas Eve and Christmas Day?
- 3Aid sent by ambulance to Ukraine front line
- 4Discovering a true sense of harmony: Contemplation and Care Practices
- 5Instructions to Utilize Your Brain science Certification to Work on Corporate Culture
- Top Pastry: What's Your Sweet Treat of Decision?
- Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026
- Commonsense Ways to work on Your Funds with a Restricted Pay
- Why don’t humans have hair all over their bodies? A biologist explains our lack of fur
- Productive CRM Programming for Client Relationship The executives
- The Main 20 Photography Instagram Records to Follow
- Czech Republic caps fuel prices amid Iran war energy crisis
- 4 Famous Attractions at Disneyland
- Chinese construction workers in Israel: 'I’d rather be bombed than live in poverty'
